Restoring America’s Leadership in Innovation Act of 2024

S.4875/H.R. 9551, the NO FAKES Act of 2023 S. 2780, the Medication Affordability and Patent Integrity Act H.R. 9455/ S. the IDEA Act H.R. 9211/S. 4840, the RESTORE Patent Rights Act of 2024 S. 5160, Sharing of information with respect to suspected violations of intellectual property rights. H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act H.R. 9474/S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Client expense: Not reported · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office

Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act) S. 4840/H.R. 9221 (RESTORE Patent Rights Act) Comments to USPTO on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO- P-2024-0003) S. 4875 (Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act) S. 2780 (Medication Affordability and Patent Integrity Act) Ensure free-market-based licensing terms and royalty rate settings of standard-essential patents (SEPs) Codification of 2019 Joint Policy Statement on Remedies for Standards-Essential Patents

31 U.S.C. 5336 - Filed in the 116th Congress as H.R.2513/S.1978 Corporate Transparency Act of 2019. To ensure that persons who form corporations or limited liability companies in the United States disclose the beneficial owners of those corporations or limited liability companies, in order to prevent wrongdoers from exploiting United States corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving United States corporations and limited liability companies, and for other purposes; H.R.20/S.567 Richard L. Trumka Protecting the Right to Organize Act of 2023. To amend the National Labor Relations Act, the Labor Management Relations Act, 1947, and the Labor-Management Reporting and Disclosure Act of 1959, and for other purposes; S.866 American Innovation and Jobs Act. To amend the Internal Revenue Code of 1986 to enhance tax benefits for research activities; H.R.1332 Thirty-Two Hour Workweek Act. To amend the Fair Labor Standards Act of 1938 to reduce the standard workweek from 40 hours per week to 32 hours per week, and for other purposes; H.R.4721/S.1706 Main Street Tax Certainty Act. To amend the Internal Revenue Code of 1986 to make permanent the deduction for qualified business income; H.R.3799 CHOICE Arrangement Act/Association Health Plans Act. To amend the Internal Revenue Code of 1986 to provide for health reimbursement arrangements integrated with individual health insurance coverage; H.R.3938 Build It in America Act. To amend the Internal Revenue Code of 1986 to encourage economic growth; H.R.3937 Small Business Jobs Act. To amend the Internal Revenue Code of 1986 to promote the establishment and growth of small businesses; H.R.3936 Tax Cuts for Working Families Act. To amend the Internal Revenue Code of 1986 to rename the standard deduction the guaranteed deduction, and to add a bonus amount to the guaranteed deduction for taxable years 2024 and 2025; H.R.3881/S.1838 Credit Card Competition Act. To amend the Electronic Fund Transfer Act to require the Board of Governors of the Federal Reserve system to prescribe regulations relating to network competition in credit card transactions, and for other purposes; H.R. 4035/S.2623 Protecting Small Business Information Act of 2023. To require the Secretary of the Treasury to harmonize the effective dates of all rules required under the Corporate Transparency Act, and for other purposes; S.1411 Prove It Act of 2023. To amend title 5, United States Code, to require greater transparency for Federal regulatory decisions that impact small businesses, and for other purposes; H.R.7198 Prove It Act of 2024. To amend title 5, United States Code, to require greater transparency for Federal regulatory decisions that impact small businesses, and for other purposes; S.1896 SCORE Act of 2023. To reauthorize the SCORE program, and for other purposes. H.R.2744 Freedom from Government Competition Act of 2023. To require that the Federal Government procure from the private sector the goods and services necessary for the operations and management of certain Government agencies, and for other purposes. H.R.4666 To require the Inspector General of the Small Business Administration to submit a quarterly report on fraud relating to certain COVID-19 loans. H.R.4667 Returning Erroneous COVID Loans Addressing Illegal and Misappropriated Taxpayer Funds (RECLAIM Taxpayer Funds) Act. To require the Administrator of the Small Business Administration to issue guidance and rules for lenders and the Small Business Administration on handling amounts of Paycheck Protection Loans returned by borrowers, and for other purposes. H.R.4668 Providing Opportunities to Show Transparency via Information Technology (POST IT) Act of 2023. To amend the Small Business Act to require the Small Business and Agriculture Regulatory Enforcement Ombudsman to publish guidance documents for certain rules, and for other purposes. H.R.4670 Small Business Contracting Transparency Act of 2023. To amend the Small Business Act to require reporting on additional information with respect to small business concerns owned and controlled by women, qualified HUBZone small business concerns, and small business concerns owned and controlled by veterans, and for other purposes. H.R.5427 To prohibit individuals convicted of defrauding the Government from receiving any assistance from the Small Business Administration, and for other purposes. H.R.4480 Successful Entrepreneurship for Reservists and Veterans (SERV) Act. To require the Administrator of the Small Business Administration to report on the veterans interagency task force, to require the Comptroller General of the United States to report on access to credit for small business concerns owned and controlled by covered individuals, and for other purposes. S.3528 Supporting Disabled Entrepreneurs Act. To amend the Small Business Act to establish the position of Coordinator for Disabled Small Business Concerns within the Office of Diversity, Inclusion and Civil Rights of the Small Business Administration, and for other purposes. H.R.5119/S.3625 Protect Small Businesses and Prevent Illicit Financial Activity Act of 2024. To amend title 31, United States Code, to provide small businesses with additional time to file beneficial ownership information, and for other purposes. H.R.7024 Tax Relief for American Families and Workers Act of 2024. To make improvements to the child tax credit, to provide tax incentives to promote economic growth, to provide special rules for the taxation of certain residents of Taiwan with income from sources within the United States, to provide tax relief with respect to certain Federal disasters, to make improvements to the low-income housing tax credit, and for other purposes. H.R.7668 ADA 30 Days to Comply Act. To amend the Americans with Disabilities Act of 1990 to provide for a remediation period before the commencement of a civil action. H.R.7473 Funding Small Businesses During Shutdown Act. To ensure continued appropriations for certain Small Business Administration programs during a Government shutdown in fiscal year 2024, and for other purposes. H.R.7963 Small Business Red Tape Relief Act of 2024. To amend title 31, United States Code, to require FinCEN to submit to Congress a quarterly report on certain beneficial ownership data. H.R.2590/S.4493 Unlocking Capital for Small Businesses Act of 2024. To amend the Securities Exchange Act of 1934 to create a safe harbor for finders and private placement brokers, and for other purposes. H.R.4764 Coordinated Support for Rural Small Businesses Act. To amend the Small Business Act to enhance the Office of Rural Affairs, and for other purposes. H.R.8132 Balancing Incentives Act of 2024. To amend title 35, United States Code, require a patent owner to consent to the filing of a petition for inter partes review or post-grant review, and for other purposes. H.R.8134 Restoring Americas Leadership in Innovation Act of 2024. To promote the leadership of the United States in global innovation by establishing a robust patent system that restores and protects the right of inventors to own and enforce private property rights in inventions and discoveries, and for other purposes. H.R.8147/S.4297 Repealing Big Brother Overreach Act. To repeal the Corporate Transparency Act. H.R.9278 To amend section 5336 of title 31, United States Code, to provide existing small businesses with an additional year to file beneficial ownership information, and for other purposes. H.R.8033 Regulatory Transparency for Small Businesses Act. To amend title 5, United States Code, to clarify the information required to be included in a certification by an agency that a rule will not have a significant economic impact on a substantial number of small entities. H.R.9031 Assurance for Small Business Act of 2024. To require Federal agency heads to submit a report on the implementation of the Regulatory Flexibility Act, and for other purposes. H.R.9032 Enhanced Regulatory Flexibility Assessment Act. To amend chapter 6 of title 5, United States Code (commonly known as the Regulatory Flexibility Act), to ensure complete analysis of potential impacts on small entities of rules, and for other purposes. H.R.9030 Regulatory Agenda Clarity Act. To amend chapter 6 of title 5, United States Code (commonly known as the Regulatory Flexibility Act), to ensure complete disclosure of an agencys annual regulatory agenda. H.R.9085 Regulatory Review Improvement Act of 2024. To amend title 5, United States Code, to make certain modifications to how agencies conduct periodic reviews of agency rules, and for other purposes. H.R.9033 Let American Businesses be On Record Act of 2024. To amend title 5, United States Code, to apply regulatory flexibility analysis requirements for the Department of Labor. S.5063 Helping Small Businesses To Hedge Risk and Insure against Volatile Expenses Act. To require the Administrator of the Small Business Administration to establish a program to allow small business concerns to purchase certain commodities futures, and for other purposes. H.R.8639/S.4260 Warehouse Worker Protection Act. To establish protections for warehouse workers, and for other purposes. In addition to contacts associated with the legislation described above: Implementation of the Corporate Transparency Act Small business tax relief Small Business Administration staffing Small Business Administration lending requirements and rules Consumer Financial Protection Bureau lending requirements Federal regulatory reform Federal privacy issues State privacy issues Independent contractor rules Joint employer rules Overtime/White-Collar Exemption rules Noncompete provisions Government funding and shutdown concerns Healthcare and paid leave issues White House Conference on Small Business Yellow Pages Test and government competition with the private sector Commodities markets and small business commodity risks Adherence to and improvement of the Regulatory Flexibility Act (RFA) Adherence to and improvement of the Small Business Regulatory Enforcement Fairness Act (SBREFA) Reauthorization of the Workforce Innovation and Opportunity Act (WIOA) Artificial Intelligence Implementation & Impacts Reducing Monopolistic Business Practices Preparation for the National Defense Authorization Act (NDAA) for Fiscal Year 2025 Preparation for Tax Cuts and Jobs Act provision expirations in 2025 Export and import concerns for small companies Streamlining federal resources and support for access to international markets Accessibility of Federal Awards for small businesses Supply chain stability

S.4875/H.R. 9551, the NO FAKES Act of 2023 S. 2780, the Medication Affordability and Patent Integrity Act H.R. 9455/ S. the IDEA Act H.R. 9211/S. 4840, the RESTORE Patent Rights Act of 2024 S. 5160, Sharing of information with respect to suspected violations of intellectual property rights. H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act H.R. 9474/S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

S. 2140: Patent Eligibility Restoration Act of 2023: Provisions regarding Section 2(b )(1 )(B)(i) and Section 2(b )(1 )(B)(ii), which exclude most inventions implemented in software from patent eligibility as these inventions are not patent ineligible in other countries. H.R. 9474: Patent Eligibility Restoration Action of 2024; all provisions of the bill. S. 2220/H.R. 4370: Promoting and Respecting Economically Vital American Innovation Leadership Act of 2023 (PREVAIL ACT): Seeking an amendment to balance incentives within the Patent Trial and Appeal Board (PTAB). H.R. 8132: Balancing Incentives Act of 2024: all provisions of the bill. H.R. 8134: Restoring America's Leadership in Innovation Act of 2024: all provisions of the bill.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2140: Patent Eligibility Restoration Act of 2023: Provisions regarding Section 2(b)(1)(B)(i) and Section 2(b)(1)(B)(ii), which exclude most inventions implemented in software from patent eligibility as these inventions are not patent ineligible in other countries. S. 2220/H.R. 4730: Promoting and Respecting Economically Vital American Innovation Leadership Act of 2023 (PREVAIL Act): Seeking an amendment to balance incentives within the Patent Trial and Appeal Board (PTAB). H.R. 8134: Restoring America's Leadership in Innovation Act of 2024: Provisions regarding restoration of injunctive relief, elimination of PTAB, restoration of patent eligibility, restoration of first to invent and declaration that a patent is a private property right. H.R. 8132: Balancing Incentives Act of 2024: Provisions regarding enabling a patent owner to decline a PTAB review.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Generic Carveouts Patent Protected Information in Drug Labels Including Issues Related to GSK v. Teva. H.R.4370/S.2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S.2140/H.R.9474: Patent Eligibility Restoration Act. H.R.6986/S.3583: To address patent thickets. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. H.R.9070/S.150: Affordable Prescriptions for Patients Act. S.142: Preserve Access to Affordable Generics and Biosimilars Act. S.4878: The Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.8134: Restoring Americas Leadership In Innovation Act of 2024. H.R.9221/S.4840: Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2024.

Client expense: $530,000 · Firm income: Not reported

Patent reform, Patent Trial and Appeal Board reform, assertion of patent exclusivity rights, H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840/H.R. 9221 (RESTORE Patent Rights Act), S. 2140/H.R. 9474 (Patent Eligibility Restoration Act), S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership Act), H.R. 3535 (Advancing Americas Interest Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

H.R. 3535 (Advancing Americas Interest Act), Bayh-Dole march-in, S. 2220/H.R. 4370 (PREVAIL Act), S. 2140 (Patent Eligibility Restoration Act), H.R. 8134 (Restoring Americas Leadership in Innovation Act), S. 4840 (RESTORE Patent Rights Act) H.R. 1 (Lower Energy Costs Act), H.R. 1640(Save Our Gas Stoves Act) Gov't. price controls Consumer welfare standard, DOJ Antitrust Div., Federal Trade Commission H.J. Res. 27/S.J. Res. 7 (Cong'l. disapproval EPA WOTUS rule) S. 1108/H.R. 7035 (Death Tax Repeal Act) H.R. 3746 (Fiscal Responsibility Act) H.R. 6758 (Defense of Property Rights Act) H.R. 7455 (Sunset Act)

Client expense: Not reported · Firm income: Not reported

Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act) S. 4840/H.R. 9221 (RESTORE Patent Rights Act) Comments to USPTO on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO- P-2024-0003) S. 4875 (Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act) S. 2780 (Medication Affordability and Patent Integrity Act)

Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act) S. 4840/H.R. 9221 (RESTORE Patent Rights Act) Comments to USPTO on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO- P-2024-0003) S. 4875 (Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act) S. 2780 (Medication Affordability and Patent Integrity Act)

General discussions regarding patent-related issues, including march-in rights, WTO TRIPS waivers S. 2140/H.R. 9474 -- Patent Eligibility Restoration Act -- sections related to treatment of patent applications and their eligible status at the USPTO H.R 4370/S. 2220 -- PREVAIL Act -- related to reforms of the PTAB process at USPTO S. 4820/H.R. 9221 -- RESTORE Patent Rights Act -- related to reforms of patent law H.R. 5475 -- Prohibiting Adversarial Patents Act -- To amend title 35, United State Code, to require the Director of the United States Patent and Trademark Office to require disclosures in patent applications regarding ties to the Peoples Republic of China and other foreign adversaries NIST Request for Information (Docket No. 230831-0207) Regarding the Draft Interagency Guidance Framework for Consideringthe Exercise of March-in Rights S. 4713 -- Inventor Diversity for Economic Advancement Act (IDEA) -- related to voluntary reporting of demographic information of patentees Clauses in grants issued by ARPA-H regarding cost for inventions created using such funding H.R. 8134 -- Restoring American Leadership in Innovation Act -- To promote the leadership of the United States in global innovation by establishing a robust patent system that restores and protects the right of inventors to own and enforce private property rights in inventions and discoveries, and for other purposes -- all sections

Client expense: Not reported · Firm income: $20,000

H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Generic Carveouts Patent Protected Information in Drug Labels Including Issues Related to GSK v. Teva. H.R.4370/S.2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S.2140: Patent Eligibility Restoration Act of 2023. H.R.6986/S.3583: To address patent thickets. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. H.R.8134: Restoring Americas Leadership in Innovation Act of 2024.

Client expense: $580,000 · Firm income: Not reported

Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE

S. 2140: Patent Eligibility Restoration Act of 2023: Provisions regarding Section 2(b )(1 )(B)(i) and Section 2(b )(1 )(B)(ii), which exclude most inventions implemented in software from patent eligibility as these inventions are not patent ineligible in other countries. S. 2220/H.R. 4370: Promoting and Respecting Economically Vital American Innovation Leadership Act of 2023 (PREVAIL ACT): Seeking an amendment to balance incentives within the Patent Trial and Appeal Board (PTAB). H.R. 8132: Balancing Incentives Act of 2024: all provisions of the bill. H.R. 8134: Restoring America's Leadership in Innovation Act of 2024: all provisions of the bill.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General discussions regarding patent-related issues, including march-in rights, WTO TRIPS waivers S. 2140 -- Patent Eligibility Restoration Act -- sections related to treatment of patent applications and their eligible status at the USPTO H.R 4370/S. 2220 -- PREVAIL Act -- related to reforms of the PTAB process at USPTO Potential legislation regarding Injunctions for patent infringers H.R. 5475 -- Prohibiting Adversarial Patents Act -- To amend title 35, United State Code, to require the Director of the United States Patent and Trademark Office to require disclosures in patent applications regarding ties to the Peoples Republic of China and other foreign adversaries NIST Request for Information (Docket No. 230831-0207) Regarding the Draft Interagency Guidance Framework for Consideringthe Exercise of March-in Rights Potential re-introduction of the IDEA Act Clauses in grants issued by ARPA-H regarding cost for inventions created using such funding H.R. 8134 -- Restoring American Leadership in Innovation Act -- To promote the leadership of the United States in global innovation by establishing a robust patent system that restores and protects the right of inventors to own and enforce private property rights in inventions and discoveries, and for other purposes -- all sections

Client expense: Not reported · Firm income: $10,000

S. 2140: Patent Eligibility Restoration Act of 2023: Provisions regarding Section 2(b)(1)(B)(i) and Section 2(b)(1)(B)(ii), which exclude most inventions implemented in software from patent eligibility as these inventions are not patent ineligible in other countries. S. 2220/H.R. 4730: Promoting and Respecting Economically Vital American Innovation Leadership Act of 2023 (PREVAIL Act): Seeking an amendment to balance incentives within the Patent Trial and Appeal Board (PTAB). H.R. 8134: Restoring America's Leadership in Innovation Act of 2024: Provisions regarding restoration of injunctive relief, elimination of PTAB, restoration of patent eligibility, restoration of first to invent and declaration that a patent is a private property right. H.R. 8132: Balancing Incentives Act of 2024: Provisions regarding enabling a patent owner to decline a PTAB review.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

CPT: Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act)